308 related articles for article (PubMed ID: 16131386)
1. Screening of blood donors for hepatitis C virus RNA with the MagNA Pure-COBAS AmpliScreen method.
Palomäki P; Wessberg S; Tuomi K; Laitinen H
Transfusion; 2005 Sep; 45(9):1518-22. PubMed ID: 16131386
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of COBAS AmpliPrep nucleic acid extraction in conjunction with COBAS AmpliScreen HBV DNA, HCV RNA and HIV-1 RNA amplification and detection.
Koppelman MH; Sjerps MC; Reesink HW; Cuypers HT
Vox Sang; 2005 Nov; 89(4):193-200. PubMed ID: 16262751
[TBL] [Abstract][Full Text] [Related]
3. Nucleic acid amplification technology screening for hepatitis C virus and human immunodeficiency virus for blood donations.
Bamaga MS; Bokhari FF; Aboud AM; Al-Malki M; Alenzi FQ
Saudi Med J; 2006 Jun; 27(6):781-7. PubMed ID: 16758035
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of NucliSens-AmpliScreen methodology to detect subtypes G of HIV-1 and 4c/4d of HCV in the screening of blood donors.
Araújo F; Henriques I; Monteiro F; Meireles E; Cruz A; Tavares G; Mota-Miranda A
Transfus Clin Biol; 2005 Oct; 12(4):331-5. PubMed ID: 16182583
[TBL] [Abstract][Full Text] [Related]
5. European multi-centre validation study of NucliSens Extractor in combination with HCV Amplicor 2.0 assay for HCV-NAT screening of plasma pools.
Cuypers HT; van Dijk R; Viret JF; Schottstedt V; Lankinen M; Da Silva Cardoso M; Lelie PN
Biologicals; 1999 Dec; 27(4):303-14. PubMed ID: 10686057
[TBL] [Abstract][Full Text] [Related]
6. Multicenter performance evaluation of a transcription-mediated amplification assay for screening of human immunodeficiency virus-1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations.
Koppelman MH; Assal A; Chudy M; Torres P; de Villaescusa RG; Reesink HW; Lelie PN; Cuypers HT
Transfusion; 2005 Aug; 45(8):1258-66. PubMed ID: 16078910
[TBL] [Abstract][Full Text] [Related]
7. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
[TBL] [Abstract][Full Text] [Related]
8. Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection.
Busch MP; Glynn SA; Wright DJ; Hirschkorn D; Laycock ME; McAuley J; Tu Y; Giachetti C; Gallarda J; Heitman J; Kleinman SH;
Transfusion; 2005 Dec; 45(12):1853-63. PubMed ID: 16371038
[TBL] [Abstract][Full Text] [Related]
9. Performance characteristics of the AmpliScreen HIV-1 test, an assay designed for screening plasma mini-pools.
Yang Y; Wisbeski MH; Mendoza M; Dorf S; Xu D; Nguyen M; Yeh S; Sun R
Biologicals; 1999 Dec; 27(4):315-23. PubMed ID: 10686058
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Roche cobas s 201 system and cobas TaqScreen multiplex test for blood screening: a European multicenter study.
Jarvis L; Becker J; Tender A; Cleland A; Queiros L; Aquiar A; Azevedo J; Aprili G; Bressan F; Torres P; Nieto S; Ursitti A; Montoro J; Vila E; Ramada C; Saldanha J
Transfusion; 2008 Sep; 48(9):1853-61. PubMed ID: 18513254
[TBL] [Abstract][Full Text] [Related]
11. Validation of the NucliSens Extractor in combination with the hepatitis C virus Cobas Amplicor 2.0 assay in four laboratories in the Netherlands utilizing nucleic acid amplification technology for blood screening.
Cuijpers HT; Molijn MH; Bos HJ; Peeters AP; van der Poel CL; Lelie PN
Vox Sang; 2001 Jul; 81(1):12-20. PubMed ID: 11520410
[TBL] [Abstract][Full Text] [Related]
12. Is an assay for simultaneous detection of hepatitis C virus core antigen and antibody a valuable alternative to nucleic acid testing?
Laperche S; Elghouzzi MH; Morel P; Asso-Bonnet M; Le Marrec N; Girault A; Servant-Delmas A; Bouchardeau F; Deschaseaux M; Piquet Y
Transfusion; 2005 Dec; 45(12):1965-72. PubMed ID: 16371051
[TBL] [Abstract][Full Text] [Related]
13. Validation of the NucliSens Extractor combined with the AmpliScreen HIV version 1.5 and HCV version 2.0 test for application in NAT minipool screening.
Jongerius JM; Sjerps M; Cuijpers HT; van Drimmelen HA; van der Poel CL; Reesink HW; Molijn MH; Peeters GA; Peeters TP; Lelie PN
Transfusion; 2002 Jun; 42(6):792-7. PubMed ID: 12147034
[TBL] [Abstract][Full Text] [Related]
14. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A
Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of an automated high-volume extraction method for viral nucleic acids in comparison to a manual procedure with preceding enrichment.
Hourfar MK; Schmidt M; Seifried E; Roth WK
Vox Sang; 2005 Aug; 89(2):71-6. PubMed ID: 16101686
[TBL] [Abstract][Full Text] [Related]
16. Experience with PCR screening.
Sun R; Jayakar H; Yeh S; Mendoza M; Wisbeski MH; Iszczyszyn W; Dragon EA
Dev Biol (Basel); 2000; 102():81-91. PubMed ID: 10794093
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of individual-donation and minipool testing to detect low-level hepatitis B virus DNA in Taiwan.
Yang MH; Li L; Hung YS; Hung CS; Allain JP; Lin KS; Tsai SJ
Transfusion; 2010 Jan; 50(1):65-74. PubMed ID: 19709394
[TBL] [Abstract][Full Text] [Related]
18. Magnetic bead technology in viral RNA and DNA extraction from plasma minipools.
Pichl L; Heitmann A; Herzog P; Oster J; Smets H; Schottstedt V
Transfusion; 2005 Jul; 45(7):1106-10. PubMed ID: 15987354
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the analytical and operational performance of two viral nucleic acid test blood screening systems: Procleix Tigris and cobas s 201.
Assal A; Barlet V; Deschaseaux M; Dupont I; Gallian P; Guitton C; Morel P; David B; De Micco P
Transfusion; 2009 Feb; 49(2):289-300. PubMed ID: 19000230
[TBL] [Abstract][Full Text] [Related]
20. Effect of viral nucleic acid testing on contamination frequency of manufacturing plasma pools.
Nübling CM; Unkelbach U; Chudy M; Seitz R
Transfusion; 2008 May; 48(5):822-6. PubMed ID: 18208414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]